PET Imaging for Head and Neck Cancers.

Journal Article (Journal Article;Review)

Head and neck cancers are commonly encountered cancers in clinical practice in the United States. Fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT has been clinically applied in staging, occult primary tumor detection, treatment planning, response assessment, follow-up, recurrent disease detection, and prognosis prediction in these patients. Alternative PET tracers remain investigational and can provide additional valuable information such as radioresistant tumor hypoxia. The recent introduction of 18F-FDG PET/MR imaging has provided the advantage of combining the superior soft tissue resolution of MR imaging with the functional information provided by 18F-FDG PET. This article is a concise review of recent advances in PET imaging in head and neck cancer.

Full Text

Duke Authors

Cited Authors

  • Marcus, C; Sheikhbahaei, S; Shivamurthy, VKN; Avey, G; Subramaniam, RM

Published Date

  • September 2021

Published In

Volume / Issue

  • 59 / 5

Start / End Page

  • 773 - 788

PubMed ID

  • 34392918

Electronic International Standard Serial Number (EISSN)

  • 1557-8275

Digital Object Identifier (DOI)

  • 10.1016/j.rcl.2021.05.005


  • eng

Conference Location

  • United States